PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.
about
DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity.Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.Directing the use of DDR kinase inhibitors in cancer treatment.Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis.MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.
P2860
PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PAXIP1 Potentiates the Combina ...... latinum Agents in Lung Cancer.
@en
PAXIP1 Potentiates the Combina ...... latinum Agents in Lung Cancer.
@nl
type
label
PAXIP1 Potentiates the Combina ...... latinum Agents in Lung Cancer.
@en
PAXIP1 Potentiates the Combina ...... latinum Agents in Lung Cancer.
@nl
prefLabel
PAXIP1 Potentiates the Combina ...... latinum Agents in Lung Cancer.
@en
PAXIP1 Potentiates the Combina ...... latinum Agents in Lung Cancer.
@nl
P2093
P2860
P1476
PAXIP1 Potentiates the Combina ...... Platinum Agents in Lung Cancer
@en
P2093
Ankita Jhuraney
Elizabeth Remily-Wood
Eric B Haura
Fumi Kinose
Gabriela Wright
Jhanelle E Gray
Jodi L Kroeger
John M Koomen
Nicholas T Woods
P2860
P304
P356
10.1158/1535-7163.MCT-15-0182
P577
2016-05-11T00:00:00Z